Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 24 ... Kagawa University.The researchers concluded: "In all collections, protease activity in the juice was very low."Kim and colleagues published their ...
2009 NOV 29 ... drugs: Reverse transcriptase inhibitors prevent the viral genome from being copied. Protease inhibitors block the maturation of new viral proteins. Scientists agree, however, that ...
Subject: Helmholtz Association of German Research Centres
2009 NOV 27 ... proteomic analyses performed on cartilage tissue extracts identified the serine protease HtrA1/PRSS11 as a major protein component of human articular cartilage, with elevated ...
2009 NOV 27 ... of the peptides generated with trypsin, chymotrypsin and Staphylococcus aureus V8 protease," wrote L. Dolcini and colleagues, University of Pavia.The researchers ...
2009 NOV 27 ... cleavage of pro-BMP4 is regulated by differential expression of a site-specific protease, we identified the PCs that cleave each site in vivo. In Xenopus oocytes, furin and PC6 ...
2009 NOV 27 ... migration. How maspin mediates these diverse effects remains unclear, as it is devoid of protease inhibitory activity," scientists writing in the Journal of Biological Chemistry ...
2009 NOV 23 ... to recent research from Towada, Japan, "Visceral adipose tissue-derived serine protease inhibitor (vaspin) has been recently identified as an adipocytokine in a rat model of ...
2009 NOV 23 ... researchers in Cologne, Germany report. "Mutations in different m-AAA protease subunits are associated with distinct neuronal disorders in human. However, the ...
2009 NOV 23 ... Resistance, Carboxypeptidase, Drug Resistance, Enzymes, Medicinal Chemistry, Protease, Therapy, Treatment, University of Liege. This article was prepared by ...
2009 NOV 23 ... ANRS mutations (cut-off=4), FDA mutations (cut-off=3), Stanford, REGA and IAS-USA major protease inhibitor (PI) mutations. Efficacy in the TITAN trial (HIV-1 RNA <50 copies/mL at ...
2009 NOV 23 ... T. W., M. B. COOKE, L. L. REDD. G. M. HUDSON, B. D. SHELMADINE, and D. S. WILLOUGHBY. Protease supplementation Improves Muscle Function after Eccentric Exercise. Med. Sci. Sports ...
2009 NOV 23 ... observed in the aortas but not in the cerebral arteries, correlated very well with protease activity and the presence of macrophages on histology. Animals on Western diets could be ...
2009 NOV 24 ... genes included those involved in endogenous antioxidant defenses (GSTA1, GSTA2) and protease inhibition (SLPI, SERPINB3). Altered expression of five genes (TLR2, IRAK2, IL1R2, ...
2009 NOV 23 ... killing than the parental strain. ZmpA or ZmpB cleavage of elafin inactivated its anti-protease activity. The effect of ZmpA and ZmpB on the neutrophil proteases elastase and cathepsin ...
2009 NOV 27 ... as inactive zymogens. Factor B is inactive at pH 7, but a catalytically active serine protease under alkaline conditions, enabling structure-activity relationship studies for 63 ...
2009 NOV 23 ... that are distinct from those obtained with a GLP1R-selective agonist. We developed a protease-resistant dual GLP1R/GCGR agonist, DualAG, and a corresponding GLP1R-selective agonist, ...
2009 NOV 23 ... The new Cat B 750 FAST™ agent is designed to complement in vitro and in vivo protease readouts from cell-based assays and VisEn's existing in vivo agent product lines, ...
